GlassScriptPrepare for your visit
Mitchell B Berger
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) · Media, PA · NPI 1083730352
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$2,419.36
in general payments reported to CMS, 2019-2025 · $504 in 2025
The $504 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $688.60
- Axonics, INC. $489.89
- Astellas Pharma US INC $362.09
- Becton, Dickinson and Company $300.00
- Sumitomo Pharma America, INC. $167.22
- Sentynl Therapeutics, INC. $158.00
Drugs and devices associated with these payments
Botox Axonics Gemtesa Bulkamid Veozah
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Mitchell Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/536440/mitchell-b-berger